Canopy Growth 4Q Loss Narrows, Revenue Rises

Dow Jones06-15
 

By Adriano Marchese

 

Canopy Growth said its fourth-quarter loss narrowed as the company's Canadian cannabis business drove revenue growth and that it expects momentum to continue in the new fiscal year.

For the three months ended March 31, the Smiths Falls, Ontario cannabis company on Monday posted a narrowed net loss of 154.7 million Canadian dollars ($110.6 million), or C$0.40 a share, compared with a loss of C$196 million, or C$1.27 a share, in the comparable quarter a year ago.

Consolidated net revenue rose 10% to C$71.2 million, missing forecasts calling for growth to C$74.3 million.

The company's cannabis revenue rose 20% in the quarter to C$54.5 million, with Canadian medical cannabis sales rising 27% and adult-use cannabis increasing by 1%.

Meanwhile, the company's vaporizer manufacturing business, Storz & Bickel, saw revenue fall 14% to C$16.8 million.

Canopy Growth said that it expects net revenue to grow in fiscal 2027 as improved cultivation practices lift gross margins while cost-cutting measures reduce operating expenses.

The company also expects to achieve positive adjusted earnings before interest, taxes, depreciation and amortization in the year, with gains weighted toward the second half of the year.

 

Write to Adriano Marchese at adriano.marchese@wsj.com

 

(END) Dow Jones Newswires

June 15, 2026 07:37 ET (11:37 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment